Major Drivers Propelling the Growth oh theEndotoxin Testing Market Forward: Rising Healthcare-Associated Infections Fuel Growth In The Endotoxin Testing Market

Global Endotoxin Testing Market

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Milestones in the Endotoxin Testing Market’s Growth Trajectory From 2025 To 2034?

In the recent past, the endotoxin testing market has been experiencing consistent growth. The market size, which was at $2.24 billion in 2024, is projected to increase to $2.31 billion in 2025, with a compound annual growth rate (CAGR) of 3.4%. Factors contributing to this growth in the historical period include an increased demand for biologics and biosimilars, heightened awareness regarding the significance of endotoxin testing, and a rise in the occurrence of infectious diseases.

In the forthcoming years, the endotoxin testing market is anticipated to witness robust expansion. This market is projected to increase to $2.91 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period is likely due to the expansion of the biopharmaceutical sector, the increasing investment in endotoxin testing research and development, and the global expansion of healthcare. The forecast period will be characterized by significant trends such as innovative endotoxin detection techniques, the uptake of endotoxin testing services, and a heightened demand for these services.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12932&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Endotoxin Testing Market?

The upward trend seen in the cases of healthcare-associated infections is projected to boost the expansion of the endotoxin testing market. These infections pertain to those contracted while receiving medical treatment, which were not existing when the patient was admitted to the hospital. Often the result of infected medical equipment or procedures, comprehensive testing is required to guarantee the safety of the patient. By evaluating the levels of bacterial endotoxins present in medical tools, particularly injectable pharmaceutical products and implanted medical devices, endotoxin testing services play an instrumental role in counteracting healthcare-associated infections. For example, the United Nations International Children’s Emergency Fund (UNICEF), a US-based organization of the UN, reported in December 2022 that pneumonia was the leading infectious disease causing child fatalities, with an annual death toll surpassing 700,000, averaging nearly 2,000 daily. Additionally, the World Health Organization, a Switzerland-based UN agency, stated in May 2022 that an estimated 24% of patients are impacted by healthcare-associated sepsis each year, with 52.3% of these patients who undergo treatment in an intensive care unit succumbing each year. Hence, the rising prevalence of healthcare-associated infections is fueling the growth of the endotoxin testing market.

Which Key Market Segments Comprise the Endotoxin Testing Market and Drive Its Revenue Growth?

The endotoxin testingmarket covered in this report is segmented –

1) By Test Type: LAL (Limulus Amebocyte Lysate) Test; Chromogenic Tests; Turbidimetric Tests; Gel Clot Tests; MAT Test; Rabbit Pyrogen Test; Recombinant Factor C (rFC) Assay

2) By Application: Medical Devices; Pharmaceuticals; Packaging; Raw Materials

3) By End-User: Hospitals; Laboratories; Research Institutes

Subsegments:

1) By LAL (Limulus Amebocyte Lysate) Test: Gel Clot LAL Test; Kinetic LAL Test; Endpoint LAL Test

2) By Chromogenic Tests: Chromogenic LAL Test; Chromogenic Factor C Assay

3) By Turbidimetric Tests: Turbidimetric LAL Test; Turbidimetric Factor C Assay

4) By Gel Clot Tests: Gel Clot LAL Test

5) By MAT Test (Monocyte Activation Test): Direct MAT; Indirect MAT

6) By Rabbit Pyrogen Test: Standard Rabbit Pyrogen Test

7) By Recombinant Factor C (rFC) Assay: RFC Assay For Endotoxin Detection

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12932&type=smp

Which Areas Are Leading Regions in the Endotoxin Testing Market Expansion Across the Globe?

North America was the largest region in the endotoxin testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in endotoxin testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Key Market Trends in theEndotoxin Testing Market Over the Coming Years?

Large-scale entities in the endotoxin testing market, such as Lonza Group AG, a pharmaceutical, biotechnology and nutrition manufacturing firm based in Switzerland, are concentrating on embracing fresh technological solutions to maintain their market leadership. In August 2023, for instance, the company introduced the Nebula absorbance reader, an innovative absorbance microplate reader designed to simplify endotoxin and pyrogen testing. This device is fully integrated with the latest version of Lonza’s WinKQCL software, eliminating the need for software users to adapt to a new platform, thereby reducing training efforts. This helps ensure data integrity compliance, accelerates training, and lightens the validation burden. With the Nebula Absorbance Reader, Lonza has introduced a state-of-the-art substitute for the ELx808, a widely accepted industry-standard absorbance reader no longer available from Lorenz. Moreover, it has been aptly created to meet the exact requirements of Lonza’s absorbance-based endotoxin assays, such as the Lonza PYROGENT 5000 Turbidimetric and Kinetic-QCL Chromogenic Endotoxin Assays, ensuring compatibility and adherence to industry standards.

View the full report here:

https://www.thebusinessresearchcompany.com/report/endotoxin-testing-global-market-report

How Is the Endotoxin Testing Market Conceptually Defined?

Endotoxin testing, or the bacterial endotoxins test (BET), refers to an in vitro assay that involves assessing bacterial endotoxin levels in substances, particularly pharmaceuticals and medical devices, to ensure product safety and compliance with quality standards. This testing helps prevent potential adverse effects on patients and users.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12932

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model